1. Nessa A, Latif SA, Siddiqui NI, Hussain MA, Drug abuse and addiction. Mymensingh Med J. 2008;17(2):227-35. https://pubmed.ncbi.nlm.nih.gov/18626465/
2. Ait-Daoud N, Blevins D, Khanna S, Sharma S, Holstege CP. Women and addiction. Psychiatric Clinic North Am. 2017;40(2):285-97.
https://doi.org/10.1016/j.psc.2017.01.005 [
DOI:10.1016/j.psc.2017.01.005.] [
PMID]
3. Babor TF, McRee BG, Kassebaum PA, Grimaldi PL, Ahmed K, Bray J. Screening, brief intervention, and referral to treatment (SBIRT):toward a public health approach to the management of substance abuse. Subst Abus. 2007;28(3):7-30. doi: 10.1300/J465v28n03_03. [
DOI:10.1300/J465v28n03_03] [
PMID]
4. Graziano S, Anzillotti L, Mannocchi G, Pichini S, Busardò FP. Screening methods for rapid determination of new psychoactive substances (NPS) in conventional and non-conventional biological matrices. J Pharm Biomed Anal. 2019;163:170-9.
https://doi.org/10.1016/j.jpba.2018.10.011 [
DOI:10.1016/j.jpba.2018.10.011.] [
PMID]
5. Tracy DK, Wood DM, Baumeister D. Novel psychoactive substances: types, mechanisms of action, and effects. BMJ. 2017;25:356. DOI: 10.1136/bmj.i6848. [
DOI:10.1136/bmj.i6848] [
PMID]
6. Bronson J, Stroop J, Zimmer S, Berzofsky M. Drug use, dependence, and abuse among state prisoners and jail inmates, 2007-2009. United States: Department of Justice, Office of Justice Programs; 2017 Jun. 27 p. Report No: NCJ 250546. https://bjs.ojp.gov/content/pub/pdf/dudaspji0709.pdf
7. Jones CM, Christensen A, Gladden RM. Increases in prescription opioid injection abuse among treatment admissions in the United States, 2004-2013. Drug Alcohol Depend. 2017;176:89-95. Doi: 10.1016/j.drugalcdep.2017.03.011. [
DOI:10.1016/j.drugalcdep.2017.03.011] [
PMID]
8. Rahimi Movaghar A, Sharifi V, Mohammadi MR, et al. Researches on substance use in Iran; 3 decades evaluation. Hakim Res J. 2006;8(4):37-44. https://www.sid.ir/en/journal/ViewPaper.aspx?id=49017.
9. Baler RD, Volkow ND. Drug addiction: the neurobiology of disrupted self-control. Trends Mol Med. 2006;12(12):559-66. doi: 10.1016/j.molmed.2006.10.005. [
DOI:10.1016/j.molmed.2006.10.005] [
PMID]
10. Sadeghi S, Fathi A. Developing a structural model of the role of social health on high-risk behaviors of young people mediated by resilience: social order. J Police Med. 2021;10 (4) :255-62. [Persian]. doi:10.30505/10.4.255.
11. Kavian M, Lavasani F, Rahimi Movaghar A,et al. Guidelines for prevention and treatment of substance dependence for mass media directors. Tehran: State Welfare Organization of Iran; 2002. 409 p. https://www.unodc.org/documents/islamicrepublicofiran/publications/Mass%20Media.pdf.
12. Siyam SH. Drug abuse prevalence between male students of different universities in Rasht in 2005. Zahedan J Res Med Sci(Tabib-e-shargh). 2007;8(4):279-85.[Persian]. https://www.sid.ir/en/journal/ViewPaper.aspx?id=84981.
13. Lozano J, García-Algar O, Vall O, De La Torre R, Scaravelli G, Pichini S. Biological matrices for the evaluation of in utero exposure to drugs of abuse. Ther Drug Monit. 2007;29(6):711-34. doi: 10.1097/FTD.0b013e31815c14ce. [
DOI:10.1097/FTD.0b013e31815c14ce] [
PMID]
14. Janicka M, Kot-Wasik A, Namieśnik J. Analytical procedures for determination of cocaine and its metabolites in biological samples. TrAC Trends Anal Chem. 2010;29(3):209-24. DOI:10.1016/j.trac.2009.12.005. [
DOI:10.1016/j.trac.2009.12.005]
15. Meinhart CD, Moskovits M, Fountain III AW, Kline ND. Rapid detection of drugs and explosives for forensic analysis. ECBC; 2018. https://apps.dtic.mil/sti/citations/AD1065041
16. Kintz P. Drug testing in addicts: a comparison between urine, sweat, and hair. Ther Drug Monit. 1996;18(4):450-5. doi: 10.1097/00007691-199608000-00024. [
DOI:10.1097/00007691-199608000-00024] [
PMID]
17. Yang PJ, Pham J, Choo J, Hu DL. Duration of urination does not change with body size. Proc Natl Acad Sci U S A. 2014;111(33):11932-7. doi: 10.1073/pnas.1402289111. [
DOI:10.1073/pnas.1402289111] [
PMID] [
PMCID]
18. Gourlay DL, Heit HA. Urine drug testing in pain medicine. JPSM. 2004;27(3):260-7. [
DOI:10.1016/j.jpainsymman.2003.07.008] [
PMID]
19. Guo L, Lin Z, Huang Z, Liang H, Jiang Y, Ye Y et al. Simple and rapid analysis of four amphetamines in human whole blood and urine using liquid-liquid extraction without evaporation/derivatization and gas chromatography-mass spectrometry. Forensic Toxicol. 2015;33(1):104-11. DOI:10.1007/s11419-014-0257-2. [
DOI:10.1007/s11419-014-0257-2]
20. Skoglund C, Hermansson U, Beck O. Clinical trial of a new technique for drugs of abuse testing: a new possible sampling technique. J Subst Abuse Treat. 2015;48(1):132-6. doi: 10.1016/j.jsat.2014.09.003. [
DOI:10.1016/j.jsat.2014.09.003] [
PMID]
21. Kumar P, Sharma A, Kumar D, Sharma L. Use of Spectroscopic Methods and their clinical applications in drug abuse: A review. Crit Rev Anal Chem. 2021;1-14. https://pubmed.ncbi.nlm.nih.gov/34376090/.
22. Boumba VA, Ziavrou KS, Vougiouklakis T. Hair as a biological indicator of drug use, drug abuse or chronic exposure to environmental toxicants. Int J Toxicol. 2006;25(3):143-63. doi: 10.1080/10915810600683028. [
DOI:10.1080/10915810600683028] [
PMID]
23. Baumgartner WA, Hill VA, Blahd WH. Hair analysis for drugs of abuse. J Forensic Sci. 1989;34(6):1433-53. DOI:10.1520/JFS12787J. [
DOI:10.1520/JFS12787J]
24. Balíková M. Hair analysis for drug abuse. Plausibility of interpretation. Biomed Pap-palacky Univ Olomouc. 2006;149(2):199-207. DOI:10.5507/bp.2005.026. [
DOI:10.5507/bp.2005.026]
25. Pragst F, Balikova MA. State of the art in hair analysis for detection of drug and alcohol abuse. Clin Chim Acta. 2006;370(1-2):17-49. doi: 10.1016/j.cca.2006.02.019. [
DOI:10.1016/j.cca.2006.02.019] [
PMID]
26. Villain M, Cirimele V, Kintz P. Hair analysis in toxicology. Clin Chem Lab Med (CCLM). 2004;42(11):1265-72.
https://doi.org/10.1515/CCLM.2004.247 [
DOI:10.1515/CCLM.2004.247.] [
PMID]
27. Savvopoulos MA, Pallis E, Tzatzarakis MN, Dialyna IA, Tzanakakis GN, Tzatzarakis AM. Legal issues of addiction assessment: the experience with hair testing in Greece. J Appl Toxicol: 2005;25(2):143-52. DOI:10.1002/jat.1047. [
DOI:10.1002/jat.1047] [
PMID]
28. Mali N, Karpe M, Kadam V. A review on biological matrices and analytical methods used for determination of drug of abuse. J Appl Pharm Sci. 2011;1(6):58-65. https://www.japsonline.com/admin/php/uploads/124_pdf.pdf
29. Klein J, Karaskov T, Koren G. Clinical applications of hair testing for drugs of abuse-the Canadian experience. Forensic Sci Int. 2000;107(1-3):281-8. doi: 10.1016/s0379-0738(99)00171-1. [
DOI:10.1016/S0379-0738(99)00171-1]
30. Cappelle D, Yegles M, Neels H, van Nuijs AL, De Doncker M, Maudens K,et al. Nail analysis for the detection of drugs of abuse and pharmaceuticals: a review. Forensic Toxicol. 2015;33(1):12-36. http://.doi.org/10.1007/s11419-014-0258-1. [
DOI:10.1007/s11419-014-0258-1]
31. Baumgartner MR. Nails: an adequate alternative matrix in forensic toxicology for drug analysis?. Bioanalysis. 2014;6(17):2189-91. doi: 10.4155/bio.14.165. [
DOI:10.4155/bio.14.165] [
PMID]
32. Hang C, Ping X, Min S. Long-term follow-up analysis of zolpidem in fingernails after a single oral dose. Anal Bioanal Chem. 2013;405(23):7281-9. doi: 10.1007/s00216-013-7188-3. [
DOI:10.1007/s00216-013-7188-3] [
PMID]
33. Shu I, Jones J, Jones M, Lewis D, Negrusz A. Detection of drugs in nails: Three year experience. J Anal Toxicol. 2015;39(8):624-8.
https://doi.org/10.1093/jat/bkv067 [
DOI:10.1093/jat/bkv067https://doi.org/10.1093/jat/bkv067.] [
PMID]
34. Huestis MA, Oyler JM, Cone EJ, Wstadik AT, Schoendorfer D, Joseph Jr RE. Sweat testing for cocaine, codeine and metabolites by gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl. 1999;733(1-2):247-64. doi: 10.1016/s0378-4347(99)00246-7 [
DOI:10.1016/S0378-4347(99)00246-7]
35. Cone EJ, Hillsgrove MJ, Jenkins AJ, Keenan RM, Darwin WD. Sweat testing for heroin, cocaine, and metabolites. J Anal Toxicol. 1994;18(6):298-305. doi: 10.1093/jat/18.6.298. [
DOI:10.1093/jat/18.6.298] [
PMID]
36. Koster RA, Alffenaar JW, Greijdanus B, VanDerNagel JE, Uges DR. Application of sweat patch screening for 16 drugs and metabolites using a fast and highly selective LC-MS/MS method. Ther Drug Monit. 2014;36(1):35-45. DOI: 10.1097/FTD.0b013e3182a04feb. [
DOI:10.1097/FTD.0b013e3182a04feb] [
PMID]
37. Kintz P, Cirimele V, Ludes B. Detection of cannabis in oral fluid (saliva) and forehead wipes (sweat) from impaired drivers. J Anal Toxicol. 2000;24(7):557-61. doi: 10.1093/jat/24.7.557. [
DOI:10.1093/jat/24.7.557] [
PMID]
38. De Giovanni N, Fucci N. The current status of sweat testing for drugs of abuse: a review. Curr Med Chem. 2013;20(4):545-61. doi: 10.2174/0929867311320040006. [
DOI:10.2174/0929867311320040006] [
PMID]
39. Huestis MA, Cone EJ, Wong CJ, Umbricht A, Preston KL. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing. J Anal Toxicol. 2000;1:24(7):509-21. doi: 10.1093/jat/24.7.509. [
DOI:10.1093/jat/24.7.509] [
PMID]
40. Cone EJ. Saliva testing for drugs of abuse. Ann N.Y Acad Sci. 1993;694(1):91-127. doi: 10.1111/j.1749-6632.1993 [
DOI:10.1111/j.1749-6632.1993.tb18346.x] [
PMID]
41. Mateos-Moreno MV, del-Río-Highsmith J, Riobóo-García R, Solá-Ruiz MF, Celemín-Viñuela A. Dental profile of a community of recovering drug addicts: Biomedical aspects. Retrospective cohort study. Med Oral, Patol Oral Cir Bucal. 2013;18(4):e671-9. doi: 10.4317/medoral.18669. [
DOI:10.4317/medoral.18669] [
PMID] [
PMCID]
42. Inscore F, Shende C, Sengupta A, Huang H, Farquharson S. Detection of drugs of abuse in saliva by surface-enhanced Raman spectroscopy (SERS). Appl Spectros. 2011;65(9):1004-8. doi: 10.1366/11-06310. [
DOI:10.1366/11-06310] [
PMID]
43. Carlsson S, Olsson R, Lindkvist I, Beck O. Application of drug testing using exhaled breath for compliance monitoring of drug addicts in treatment. Scand J Clin ab Invest. 2015;75(2):156-61. DOI: 10.3109/00365513.2014.993336. [
DOI:10.3109/00365513.2014.993336] [
PMID]
44. Beck O, Leine K, Palmskog G, Franck J. Amphetamines detected in exhaled breath from drug addicts: a new possible method for drugs-of-abuse testing. J Toxicol. 2010;34(5):233-7. doi: 10.1093/jat/34.5.233. [
DOI:10.1093/jat/34.5.233] [
PMID]
45. Arvidsson M, Ullah S, Franck J, Dahl ML, Beck O. Drug abuse screening with exhaled breath and oral fluid in adults with substance use disorder. Drug Test Ana. 2019;11(1):27-32. doi: 10.1002/dta.2384. [
DOI:10.1002/dta.2384] [
PMID]
46. Beck O. Exhaled breath for drugs of abuse testing-evaluation in criminal justice settings. Sci Justice. 2014;54(1):57-60. DOI: 10.1016/j.scijus.2013.09.007. [
DOI:10.1016/j.scijus.2013.09.007] [
PMID]